Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty® COVID-19 vaccine.
Giménez E, Albert E, Burgos JS, Peiró S, Salas D, Vanaclocha H, Limón R, Alcaraz MJ, Sánchez-Payá J, Díez-Domingo J, Comas I, Gonzáles-Candelas F; Valencian vaccine research program (ProVaVac) study group. Giménez E, et al. Among authors: comas i. J Infect. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.02.035. Epub 2022 Mar 2. J Infect. 2022. PMID: 35245583 Free PMC article.
Burgos JS (General Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain); Meneu de Guillerna R (Vice-President Foundation Research Institute in Public Services, Valencia, Spain); Vanaclocha Luna H (General Directorate of P …
Burgos JS (General Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain); Meneu de …
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.
Hodcroft EB, Zuber M, Nadeau S, Vaughan TG, Crawford KHD, Althaus CL, Reichmuth ML, Bowen JE, Walls AC, Corti D, Bloom JD, Veesler D, Mateo D, Hernando A, Comas I, González-Candelas F; SeqCOVID-SPAIN consortium; Stadler T, Neher RA. Hodcroft EB, et al. Among authors: comas i. Nature. 2021 Jul;595(7869):707-712. doi: 10.1038/s41586-021-03677-y. Epub 2021 Jun 7. Nature. 2021. PMID: 34098568
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant.
López MG, Chiner-Oms Á, García de Viedma D, Ruiz-Rodriguez P, Bracho MA, Cancino-Muñoz I, D'Auria G, de Marco G, García-González N, Goig GA, Gómez-Navarro I, Jiménez-Serrano S, Martinez-Priego L, Ruiz-Hueso P, Ruiz-Roldán L, Torres-Puente M, Alberola J, Albert E, Aranzamendi Zaldumbide M, Bea-Escudero MP, Boga JA, Bordoy AE, Canut-Blasco A, Carvajal A, Cilla Eguiluz G, Cordón Rodríguez ML, Costa-Alcalde JJ, de Toro M, de Toro Peinado I, Del Pozo JL, Duchêne S, Fernández-Pinero J, Fuster Escrivá B, Gimeno Cardona C, González Galán V, Gonzalo Jiménez N, Hernáez Crespo S, Herranz M, Lepe JA, López-Causapé C, López-Hontangas JL, Martín V, Martró E, Milagro Beamonte A, Montes Ros M, Moreno-Muñoz R, Navarro D, Navarro-Marí JM, Not A, Oliver A, Palop-Borrás B, Parra Grande M, Pedrosa-Corral I, Pérez González MC, Pérez-Lago L, Pérez-Ruiz M, Piñeiro Vázquez L, Rabella N, Rezusta A, Robles Fonseca L, Rodríguez-Villodres Á, Sanbonmatsu-Gámez S, Sicilia J, Soriano A, Tirado Balaguer MD, Torres I, Tristancho A, Marimón JM; SeqCOVID-Spain consortium; Coscolla M, González-Candelas F, Comas I. López MG, et al. Among authors: comas i. Nat Genet. 2021 Oct;53(10):1405-1414. doi: 10.1038/s41588-021-00936-6. Epub 2021 Sep 30. Nat Genet. 2021. PMID: 34594042 Free PMC article.
Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents.
Albert E, Burgos JS, Peiró S, Salas D, Vanaclocha H, Giménez E, Limón R, Alcaraz MJ, Sánchez-Payá J, Díez-Domingo J, Navarro D; Valencian Vaccine Research Programme (ProVaVac) Study Group. Albert E, et al. Clin Microbiol Infect. 2022 Feb;28(2):279-284. doi: 10.1016/j.cmi.2021.09.031. Epub 2021 Oct 5. Clin Microbiol Infect. 2022. PMID: 34619398 Free PMC article.
Persistent SARS-CoV-2 infection with repeated clinical recurrence in a patient with common variable immunodeficiency.
Cabañero-Navalon MD, Garcia-Bustos V, Ruiz-Rodriguez P, Comas I, Coscollá M, Martinez-Priego L, Todolí J, Moral Moral P. Cabañero-Navalon MD, et al. Among authors: comas i. Clin Microbiol Infect. 2022 Feb;28(2):308-310. doi: 10.1016/j.cmi.2021.10.021. Epub 2021 Nov 10. Clin Microbiol Infect. 2022. PMID: 34774757 Free PMC article. No abstract available.
Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine.
Giménez E, Albert E, Zulaica J, Torres I, Rusu L, Moreno AR, Burgos JS, Peiró S, Salas D, Vanaclocha H, Limón R, Alcaraz MJ, Sánchez-Payá J, Díez-Domingo J, Comas I, Gonzáles-Candelas F, Geller R, Navarro D; Valencian Vaccine Research Program (ProVaVac) Study Group. Giménez E, et al. Among authors: comas i. Clin Infect Dis. 2022 Aug 24;75(1):e865-e868. doi: 10.1093/cid/ciac223. Clin Infect Dis. 2022. PMID: 35314856 Free PMC article.
SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination.
Torres I, Bellido-Blasco JB, Gimeno C, Burgos JS, Albert E, Moya-Malo R, Gascó-Laborda JC, Tornero A, Soriano J, Meseguer-Ferrer N, Martínez-Serrano M, Ortíz-Rambla J, Buj H, Hernández N, Peiró S, Salas D, Limón R, Vanaclocha H, Sánchez-Payá J, Díez-Domingo J, Comas I, González-Candelas F, Navarro D; Valencian vaccine research program (ProVaVac) study group. Torres I, et al. Among authors: comas i. J Med Virol. 2022 Aug;94(8):3776-3782. doi: 10.1002/jmv.27799. Epub 2022 Apr 27. J Med Virol. 2022. PMID: 35445415 Free PMC article.
SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection.
Torres I, Giménez E, Albert E, Zulaica J, Álvarez-Rodríguez B, Burgos JS, Peiró S, Limón R, Vanaclocha H, Rodado C, Botija P, Sifre A, Tur B, Lozano RA, Orosa I, Vicente-Ruiz M, Carrión RJ, Clari MÁ, Sánchez-Payá J, Díez-Domingo J, Comas I, González-Candelas F, Geller R, Navarro D; Valencian vaccine research program (ProVaVac) study group. Torres I, et al. Among authors: comas i. J Med Virol. 2022 Sep;94(9):4216-4223. doi: 10.1002/jmv.27867. Epub 2022 May 25. J Med Virol. 2022. PMID: 35585782 Free PMC article.
Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant.
Camacho J, Giménez E, Albert E, Zulaica J, Álvarez-Rodríguez B, Torres I, Rusu L, Burgos JS, Peiró S, Vanaclocha H, Limón R, Alcaraz MJ, Sánchez-Payá J, Díez-Domingo J, Comas I, Gonzáles-Candelas F, Geller R, Navarro D; Valencian Vaccine Research Program (ProVaVac) study group. Camacho J, et al. Among authors: comas i. J Med Virol. 2023 Jan;95(1):e28284. doi: 10.1002/jmv.28284. Epub 2022 Nov 11. J Med Virol. 2023. PMID: 36333837 Free PMC article.
Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis.
García-Marín AM, Cancino-Muñoz I, Torres-Puente M, Villamayor LM, Borrás R, Borrás-Máñez M, Bosque M, Camarena JJ, Colomer-Roig E, Colomina J, Escribano I, Esparcia-Rodríguez O, Gil-Brusola A, Gimeno C, Gimeno-Gascón A, Gomila-Sard B, González-Granda D, Gonzalo-Jiménez N, Guna-Serrano MR, López-Hontangas JL, Martín-González C, Moreno-Muñoz R, Navarro D, Navarro M, Orta N, Pérez E, Prat J, Rodríguez JC, Ruiz-García MM, Vanaclocha H; Valencia Region Tuberculosis Working Group; González-Candelas F, Furió V, Comas I. García-Marín AM, et al. Among authors: comas i. Lancet Microbe. 2024 Jan;5(1):e43-e51. doi: 10.1016/S2666-5247(23)00252-5. Epub 2023 Dec 4. Lancet Microbe. 2024. PMID: 38061383 Free PMC article.
162 results